Baici A, Lang A, Hörler D, Kissling R, Merlin C
Department of Rheumatology, University Hospital, Zurich, Switzerland.
Ann Rheum Dis. 1995 Apr;54(4):289-97. doi: 10.1136/ard.54.4.289.
To localise the cysteine endopeptidase cathepsin B in chondrocytes and cartilage from normal and osteoarthritic (OA) human femoral heads in order to provide qualitative information on its cellular expression and distribution at possible sites of action.
OA articular cartilage was obtained at surgery for total hip replacement; control cartilage was obtained at postmortem. Chondrocytes were isolated by sequential enzymatic digestion and cathepsin B analysed by immunocytochemistry and activity staining with a fluorogenic substrate. Lysosomes were visualised by fluorescence microscopy after staining of living cells with acridine orange. Using a histochemical reaction, enzyme activity was measured in cryosections of full thickness cartilage.
Chondrocytes from normal cartilage contained very few lysosomes and only a minor cell population was cathepsin B positive. A high proportion of chondrocytes from active OA cartilage contained a large number of lysosomes and an excess of cathepsin B in intracellular organelles; the enzyme was stored in an active form. In this respect, OA chondrocytes closely resembled normal cells that had been phenotypically modulated by serial subcultures. No cathepsin B activity could be detected by histochemistry in either chondrocytes or matrix of normal cartilage. While apparently intact and severely degraded OA cartilage was also cathepsin B negative, tissue at sites of active destruction and, particularly, at repair sites was highly positive.
The presence and the particular distribution of active cathepsin B in OA cartilage at 'more involved' sites suggest a pathological role for this enzyme in sustaining and perpetuating cartilage degradation. While other stimuli may also be responsible for cathepsin B expression in OA chondrocytes, the similarity with artificially modulated cells indicates fibroblastic metaplasia as a plausible mechanism.
将半胱氨酸内肽酶组织蛋白酶B定位在正常和骨关节炎(OA)人股骨头的软骨细胞及软骨中,以便提供关于其在可能作用位点的细胞表达和分布的定性信息。
OA关节软骨取自全髋关节置换手术;对照软骨取自尸检。通过连续酶消化分离软骨细胞,并用免疫细胞化学和荧光底物活性染色分析组织蛋白酶B。用吖啶橙对活细胞染色后,通过荧光显微镜观察溶酶体。使用组织化学反应,在全层软骨的冰冻切片中测量酶活性。
正常软骨的软骨细胞含有极少的溶酶体,只有少数细胞群组织蛋白酶B呈阳性。来自活跃OA软骨的高比例软骨细胞含有大量溶酶体,细胞内细胞器中有过量的组织蛋白酶B;该酶以活性形式储存。在这方面,OA软骨细胞与经连续传代培养进行表型调节的正常细胞非常相似。在正常软骨的软骨细胞或基质中,组织化学均未检测到组织蛋白酶B活性。虽然明显完整和严重降解的OA软骨组织蛋白酶B也呈阴性,但在活跃破坏部位,特别是修复部位的组织呈高度阳性。
活性组织蛋白酶B在OA软骨“病变更严重”部位的存在及其特殊分布表明该酶在维持和延续软骨降解中起病理作用。虽然其他刺激因素也可能导致OA软骨细胞中组织蛋白酶B的表达,但与人工调节细胞的相似性表明成纤维细胞化生是一种合理的机制。